| CWIEX | RGDTX | CWIEX / RGDTX | |
| Total Expense Ratio | 1.00 | 0.88 | 114% |
| Annual Report Gross Expense Ratio | 1.00 | 1.01 | 99% |
| Fund Existence | 24 years | 9 years | - |
| Gain YTD | 24.404 | 21.900 | 111% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 142B | 2.38B | 5,964% |
| Annual Yield % from dividends | 1.14 | 0.92 | 124% |
| Returns for 1 year | 13.86 | 10.40 | 133% |
| Returns for 3 years | 54.55 | 56.34 | 97% |
| Returns for 5 years | 45.37 | 21.41 | 212% |
| Returns for 10 years | 111.03 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IVGAX | 19.82 | 0.17 | +0.87% |
| VY® Invesco Growth and Income A | |||
| FGSAX | 61.79 | 0.47 | +0.77% |
| Federated Hermes MDT Mid Cap Growth A | |||
| SWANX | 26.70 | 0.05 | +0.19% |
| Schwab Core Equity | |||
| WSCRX | 38.89 | N/A | N/A |
| Allspring Small Company Growth R6 | |||
| PHPSX | 28.88 | -0.14 | -0.48% |
| ProFunds Pharmaceuticals UltraSector Svc | |||